292 related articles for article (PubMed ID: 22666624)
1. Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis.
Noda M; Suzumura A
Int J Alzheimers Dis; 2012; 2012():891087. PubMed ID: 22666624
[TBL] [Abstract][Full Text] [Related]
2. Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology.
Lau SF; Fu AKY; Ip NY
J Neurochem; 2023 Sep; 166(6):891-903. PubMed ID: 37603311
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease.
Keaney J; Gasser J; Gillet G; Scholz D; Kadiu I
J Neuroimmune Pharmacol; 2019 Sep; 14(3):448-461. PubMed ID: 30758770
[TBL] [Abstract][Full Text] [Related]
4. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease.
Das R; Chinnathambi S
Neuroscience; 2020 Nov; 448():325-336. PubMed ID: 32941933
[TBL] [Abstract][Full Text] [Related]
5. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system diseases related to pathological microglial phagocytosis.
Wang K; Li J; Zhang Y; Huang Y; Chen D; Shi Z; Smith AD; Li W; Gao Y
CNS Neurosci Ther; 2021 May; 27(5):528-539. PubMed ID: 33650762
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation and its implications in the brain diseases.
Dheen ST; Kaur C; Ling EA
Curr Med Chem; 2007; 14(11):1189-97. PubMed ID: 17504139
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons.
Rajbhandari L; Tegenge MA; Shrestha S; Ganesh Kumar N; Malik A; Mithal A; Hosmane S; Venkatesan A
Glia; 2014 Dec; 62(12):1982-91. PubMed ID: 25042766
[TBL] [Abstract][Full Text] [Related]
9. Microglia in Alzheimer's disease.
Sarlus H; Heneka MT
J Clin Invest; 2017 Sep; 127(9):3240-3249. PubMed ID: 28862638
[TBL] [Abstract][Full Text] [Related]
10. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
11. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.
Rogers J; Lue LF
Neurochem Int; 2001; 39(5-6):333-40. PubMed ID: 11578768
[TBL] [Abstract][Full Text] [Related]
12. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
13. Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction.
Konishi H; Okamoto T; Hara Y; Komine O; Tamada H; Maeda M; Osako F; Kobayashi M; Nishiyama A; Kataoka Y; Takai T; Udagawa N; Jung S; Ozato K; Tamura T; Tsuda M; Yamanaka K; Ogi T; Sato K; Kiyama H
EMBO J; 2020 Nov; 39(22):e104464. PubMed ID: 32959911
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of microglial cathepsins in neurodegenerative disease.
Lowry JR; Klegeris A
Brain Res Bull; 2018 May; 139():144-156. PubMed ID: 29454581
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.
Johansson JU; Woodling NS; Wang Q; Panchal M; Liang X; Trueba-Saiz A; Brown HD; Mhatre SD; Loui T; Andreasson KI
J Clin Invest; 2015 Jan; 125(1):350-64. PubMed ID: 25485684
[TBL] [Abstract][Full Text] [Related]
16. Microglial phagocytosis in aging and Alzheimer's disease.
Gabandé-Rodríguez E; Keane L; Capasso M
J Neurosci Res; 2020 Feb; 98(2):284-298. PubMed ID: 30942936
[TBL] [Abstract][Full Text] [Related]
17. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid microglial antibodies: potential diagnostic markers for immune mechanisms in Alzheimer's disease.
McRae A; Dahlström A; Polinsky R; Ling EA
Behav Brain Res; 1993 Nov; 57(2):225-34. PubMed ID: 8117427
[TBL] [Abstract][Full Text] [Related]
19. Microglial debris is cleared by astrocytes via C4b-facilitated phagocytosis and degraded via RUBICON-dependent noncanonical autophagy in mice.
Zhou T; Li Y; Li X; Zeng F; Rao Y; He Y; Wang Y; Liu M; Li D; Xu Z; Zhou X; Du S; Niu F; Peng J; Mei X; Ji SJ; Shu Y; Lu W; Guo F; Wu T; Yuan TF; Mao Y; Peng B
Nat Commun; 2022 Oct; 13(1):6233. PubMed ID: 36280666
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation.
Anwar S; Rivest S
Expert Opin Ther Targets; 2020 Apr; 24(4):331-344. PubMed ID: 32129117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
